Tong, NJ
Anita Tong, Westfield, NJ US
Patent application number | Description | Published |
---|---|---|
20120171132 | COMPOSITION CONTAINING AN ALKOXYSILANE AND HYALURONIC ACID - A composition comprising: at least one alkoxysilane having at least one solubilizing functional group and at least one amino substituent; at least one glycosaminoglycan chosen from hyaluronic acid; water; optionally, at least one auxiliary ingredient; and optionally, at least one volatile solvent. | 07-05-2012 |
20120171140 | REACTION PRODUCT OF A POLAR MODIFIED POLYMER AND AN ALKOXYSILANE AND A COMPOSITION CONTAINING THE REACTION PRODUCT - The invention relates to a reaction product of a polar modified polymer and an alkoxysilane having at least one solubilizing functional group and at least one amino substituent. | 07-05-2012 |
20130224130 | COSMETIC COMPOSITION FOR LONG-WEARING PROPERTIES - Disclosed are cosmetic compositions comprising (1) at least one MQTPr siloxane resin; (2) at least one film former chosen from a silicone acrylate copolymer; (3) at least one film former chosen from a hydrogenated hydrocarbon copolymer; (4) at least one fatty phase; and (5) optionally at least one wax and/or colorant. Also disclosed are methods for improving at least one property of a cosmetic composition, and methods for making up and/or enhancing the appearance of keratinous substrates using compositions according to the invention. | 08-29-2013 |
Anita Chon Tong, Garwood, NJ US
Patent application number | Description | Published |
---|---|---|
20100129307 | COSMETIC COMPOSITIONS WITH A SPONGY TEXTURE - The present invention concerns a cosmetic composition comprising: | 05-27-2010 |
20110300088 | WATER-INSOLUBLE REACTION PRODUCT OF A POLYAMINE AND AN OIL-SOLUBLE POLAR MODIFIED POLYMER - The invention relates to a water-insoluble reaction product of an oil-soluble polar modified polymer and a polyamine. | 12-08-2011 |
20110305658 | LENGTHENING MASCARA COMPOSITION - The present invention is directed to a lengthening and smudge proof mascara composition for making up eye lashes having: (a) at least one alkyl ethoxylated polymer wax; (b) at least one oil soluble polar modified polymer; (c) at least one oil soluble high carbon polar modified polymer; (d) water; (e) at least one non-volatile oil capable of solubilizing the polar modified polymers; (f) optionally, at least one volatile solvent; and (g) optionally, at least one colorant, and wherein the composition does not require fibers to be dispersed therein. | 12-15-2011 |
20120004327 | WATER-INSOLUBLE REACTION PRODUCT OF A POLYAMINE AND AN OIL-SOLUBLE HIGH CARBON POLAR MODIFIED POLYMER - The invention relates to a water-insoluble reaction product of an oil-soluble high carbon polar modified polymer and a polyamine. | 01-05-2012 |
20120095113 | REFRESHING CREAM FOUNDATION IN GEL FORM - The present invention is directed to a cosmetic composition includes (a) at least one compound selected from a sugar silicone surfactant, a gelling agent, a polyamine and a hyperbranched polyol; and (b) at least one polar modified polymer. | 04-19-2012 |
20120100090 | COMPOSITION COMPRISING A POLAR MODIFIED POLYMER - The invention relates to a composition comprising (1) at least one polar modified polymer, (2) at least one compound selected from a hyperbranched polyol having at least two hydroxyl groups, a sugar silicone surfactant, and a gelling agent. | 04-26-2012 |
20120107263 | LONG-WEAR, WATERPROOF AND WASHABLE MASCARA COMPOSITION - The present invention is directed to long wear, washable and waterproof eye makeup composition containing: (a) at least one polyamine; (b) at least one oil-soluble polar modified polymer; (c) water; (d) at least one non-volatile oil capable of solublizing the oil-soluble polar modified polymer; (d) at least one volatile solvent; (e) optionally, at least one colorant; and (f) optionally, at least one wax, wherein the composition does not require a latex film former or surfactant/emulsifier. | 05-03-2012 |
Hui Tong, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20100166001 | Boundary Routers Providing Redistribution and Related Backbone Networks, Computer Program Products, and Methods - A backbone network may include first and second border routers and a route reflector. The first border router may provide data connectivity between the backbone network and a first regional network. The first border router may be configured to receive a notification of a change in status of an edge router of the first regional network, and the notification may be received according to a first routing protocol. The first border router may be further configured to redistribute the notification of the change in status of the edge router from the first routing protocol to a second routing protocol with the first and second routing protocols being different. The second border router may provide data connectivity between the backbone network and a second regional network. The route reflector may be coupled between the first and second border routers, and the route reflector may be configured to transfer the redistributed notification from the first border router to the second border router. Related routers, methods, and computer program products are also discussed. | 07-01-2010 |
Hung-Huar Tong, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100286100 | Method and composition to improve absorption of therapeutic agents - A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling. The blend is then compressed to form tablets that have an enhanced dissolution profile for the medicinally active ingredient. | 11-11-2010 |
20110300216 | Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives - A tablet comprising: (a) an active ingredient; and (b) at least one member of an effervescent couple, wherein said tablet dissolves in water in not more than three minutes and in the mouth in not more than thirty seconds, and wherein said tablet is capable of acting as an effervescent tablet, a rapid-dissolve tablet or a rapidly disintegrating swallow tablet. | 12-08-2011 |
20130122098 | Method and composition to improve absorption of therapeutic agents - A tablet with an enhanced dissolution profile for a medicinally active ingredient such as aspirin and methods for making the tablet. The tablet comprises a blend of crystals of the medicinally active ingredient and a dissolution aid such as sodium or calcium carbonate or bicarbonate that coats the crystals upon co-milling. The blend is then compressed to form tablets that have an enhanced dissolution profile for the medicinally active ingredient. | 05-16-2013 |
Jianliang Tong, Newark, NJ US
Patent application number | Description | Published |
---|---|---|
20150051508 | System and Method for Cognition and Oculomotor Impairment Diagnosis Using Binocular Coordination Analysis - A method of testing a subject for impairment includes presenting the subject with a display of a smoothly moving object, repeatedly moving over a tracking path and, while presenting the display to the subject, measuring the subject's right eye positions and measuring the subject's left eye positions. The method further includes generating a disconjugacy metric by comparing the measured right eye positions with the measured left eye positions, comparing the disconjugacy metric with a predetermined baseline to determine whether the disconjugacy metric is indicative of an impairment, and generating a report based on the disconjugacy metric. | 02-19-2015 |
Jun Hua Tong, Jersey City, NJ US
Patent application number | Description | Published |
---|---|---|
20150064224 | Use of Certain Water-Insoluble Porous Polymeric Particles in Spherical Form as SPF Boosters - The present invention relates to a composition intended for protecting the skin and/or hair against ultraviolet radiation containing: (a) at least one photoprotective system capable of screening out UV radiation; and (b) water-insoluble polymeric porous particles in spherical form. | 03-05-2015 |
Ling Tong, Warren, NJ US
Patent application number | Description | Published |
---|---|---|
20090111803 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): | 04-30-2009 |
20090137586 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): | 05-28-2009 |
20090156586 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): | 06-18-2009 |
20090170875 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): | 07-02-2009 |
20100120838 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): | 05-13-2010 |
20110288054 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I) as described herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof. | 11-24-2011 |
20110288077 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISEASES - This invention relates to compounds of the Formula (I)-(IX):, as defined herein, or a pharmaceutically acceptable salt, solvate or ester thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF-α combinations thereof. | 11-24-2011 |
20120010181 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt, solvate or isomer thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF—or combinations thereof. | 01-12-2012 |
20120015926 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS - This invention relates to compounds of the Formula (I): (Chemical formula should be inserted here as it appears on abstract in paper form) (I) or a pharmaceutically acceptable salt thereof, which can be useful for the treatment of diseases or conditions mediated by MMPs, ADAMs, TACE, aggrecanase, TNF- or combinations thereof. | 01-19-2012 |
20140242027 | SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS - The present invention provides compounds of Formula (I): and tautomers, isomers, and esters of said compounds, and pharmaceutically acceptable salts, solvates, and prodrugs of said compounds, wherein each of R, R | 08-28-2014 |
20140378416 | SILYL-CONTAINING HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF VIRAL DISEASES - The present invention relates to novel Silyl-Containing Heterocyclic Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, E, F and L are as defined herein. The present invention also relates to compositions comprising at least one Silyl-Containing Heterocyclic Compound, and methods of using the Silyl-Containing Heterocyclic Compounds for treating or preventing HCV infection in a patient. | 12-25-2014 |
20150266895 | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS - Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1). | 09-24-2015 |
Ling Tong, Rahway, NJ US
Patent application number | Description | Published |
---|---|---|
20150266895 | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS - Disclosed are the ERK inhibitors of formula (1): and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1). | 09-24-2015 |
Wei Tong, Piscataway, NJ US
Patent application number | Description | Published |
---|---|---|
20100297499 | SILVER OXYFLUORIDE ELECTRODE COMPOSITIONS AND METHODS - The present invention relates to a novel class of silver oxyfluoride based electrode materials based on the perovskite structure used in primary and rechargeable electromechanical energy storage systems. | 11-25-2010 |
Wein-Qin Tong, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100152299 | Process for making compositions with poorly compressible therapeutic compounds - A process for preparing solid dosage forms that contain poorly compressible therapeutic compound. The process, for example, provides for the inventive use of an extruder, especially a twin screw extruder, to melt granulate a therapeutic compound(s) with a granulation excipient. | 06-17-2010 |
Wei-Quin Tong, Basking Ridge, NJ US
Patent application number | Description | Published |
---|---|---|
20100038816 | METHOD OF MAKING SOLID DISPERSIONS OF HIGHLY CRYSTALLINE THERAPEUTIC COMPOUNDS - A process for preparing solid dispersions of highly crystalline compounds. The highly crystalline or thermally labile therapeutic compounds are processed in an extruder in combination with a solubilizing agent and optionally a plasticizer. The resulting extrudate features the therapeutic compound in an amorphous state. Particularly useful as the solubilizing agents are surfactants such as poloxamers. | 02-18-2010 |
Xiao Tong, Short Hills, NJ US
Patent application number | Description | Published |
---|---|---|
20090209483 | TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION - The present invention provides methods for treating infections, in a host, by viruses belonging to the Flaviviridae family, such as HCV, comprising administering an Ara-C homologue to the host. | 08-20-2009 |
20110033422 | TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION - The present invention provides methods for treating infections, in a host, by viruses belonging to the Flaviviridae family, such as HCV, comprising administering an Ara-C homologue to the host. | 02-10-2011 |
Xiaomei Tong, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20120228519 | System and Method for Fluorescence and Absorbance Analysis - A system or method for analyzing a sample include an input light source, a double subtractive monochromator positioned to receive light from the input light source and to sequentially illuminate the sample with each of a plurality of wavelengths, a multi-channel fluorescence detector positioned to receive and substantially simultaneously detect multiple wavelengths of light emitted by the sample for each of the plurality of excitation wavelengths, an absorption detector positioned to receive and detect light passing through the sample, and a computer in communication with the monochromator, the fluorescence detector, and the absorption detector, the computer controlling the monochromator to sequentially illuminate the sample with each of the plurality of wavelengths while measuring absorption and fluorescence of the sample based on signals received from the fluorescence and absorption detectors | 09-13-2012 |
Xiaomei May Tong, Edison, NJ US
Patent application number | Description | Published |
---|---|---|
20150083903 | SYSTEM AND METHOD FOR FLUORESCENCE AND ABSORBANCE ANALYSIS - A system or method for analyzing a sample include an input light source, an excitation light source positioned to receive light from the input light source and to sequentially illuminate the sample with each of a plurality of wavelengths, a fluorescence detector positioned to receive and substantially simultaneously detect multiple wavelengths of light emitted by the sample for each of the plurality of excitation wavelengths, an absorption detector positioned to receive and detect light passing through the sample, and a computer in communication with the excitation light source, the fluorescence detector, and the absorption detector, the computer controlling the excitation light source to sequentially illuminate the sample with each of the plurality of wavelengths while measuring absorption and fluorescence of the sample based on signals received from the fluorescence and absorption detectors. | 03-26-2015 |